2Seventy Net Invested Capital vs Cash And Short Term Investments Analysis

TSVT Stock

USD 4.13 0.43 9.43%

2Seventy Bio financial indicator trend analysis is way more than just evaluating 2Seventy Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether 2Seventy Bio is a good investment. Please check the relationship between 2Seventy Bio Net Invested Capital and its Cash And Short Term Investments accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.

Net Invested Capital vs Cash And Short Term Investments

Net Invested Capital vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of 2Seventy Bio Net Invested Capital account and Cash And Short Term Investments. At this time, the significance of the direction appears to have totally related.

The correlation between 2Seventy Bio's Net Invested Capital and Cash And Short Term Investments is 1.0. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of 2Seventy Bio, assuming nothing else is changed. The correlation between historical values of 2Seventy Bio's Net Invested Capital and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of 2Seventy Bio are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Net Invested Capital i.e., 2Seventy Bio's Net Invested Capital and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

1.0

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of 2Seventy Bio balance sheet. This account contains 2Seventy Bio investments that will expire within one year. These investments include stocks and bonds that can be liquidated by 2Seventy Bio fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most indicators from 2Seventy Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into 2Seventy Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.Selling General Administrative is likely to gain to about 86.4 M in 2024, whereas Tax Provision is likely to drop 0.00 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	52.0M	65.3M	73.2M	70.4M
Total Revenue	54.5M	91.5M	100.4M	108.8M

Gross Profit Total Revenue

2Seventy Bio fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital
Common Stock Shares Outstanding		0.57	0.7	-0.85	-0.84	0.63	-0.86	0.74	0.48	0.48	-0.64	-0.65	0.68	0.27	0.72	0.85	0.64	0.59	-0.82	0.6	0.7	-0.56	0.04	0.84	0.4	0.63
Total Assets	0.57		0.99	-0.18	-0.57	0.99	-0.83	0.96	0.95	0.06	-0.96	-0.83	0.98	0.92	0.97	0.43	0.99	0.93	-0.51	1.0	0.99	-0.98	0.25	0.86	0.96	0.99
Short Long Term Debt Total	0.7	0.99		-0.32	-0.65	0.99	-0.9	0.98	0.93	0.15	-0.96	-0.84	0.99	0.86	0.99	0.54	0.99	0.93	-0.61	0.99	1.0	-0.96	0.21	0.92	0.92	0.99
Other Current Liab	-0.85	-0.18	-0.32		0.85	-0.25	0.61	-0.39	-0.17	-0.57	0.35	0.48	-0.34	0.09	-0.31	-0.8	-0.25	-0.25	0.83	-0.22	-0.32	0.22	-0.06	-0.61	0.01	-0.25
Total Current Liabilities	-0.84	-0.57	-0.65	0.85		-0.63	0.81	-0.69	-0.59	-0.29	0.69	0.85	-0.68	-0.34	-0.6	-0.78	-0.6	-0.67	0.83	-0.58	-0.65	0.58	-0.09	-0.82	-0.36	-0.63
Total Stockholder Equity	0.63	0.99	0.99	-0.25	-0.63		-0.85	0.98	0.94	0.04	-0.96	-0.87	0.98	0.89	0.97	0.46	1.0	0.95	-0.54	0.99	0.99	-0.97	0.23	0.87	0.93	1.0
Other Liab	-0.86	-0.83	-0.9	0.61	0.81	-0.85		-0.87	-0.83	-0.4	0.86	0.77	-0.9	-0.62	-0.9	-0.85	-0.85	-0.85	0.81	-0.85	-0.9	0.79	-0.01	-0.99	-0.74	-0.85
Net Tangible Assets	0.74	0.96	0.98	-0.39	-0.69	0.98	-0.87		0.87	0.12	-0.95	-0.88	0.97	0.81	0.97	0.51	0.99	0.91	-0.61	0.97	0.98	-0.95	0.27	0.89	0.86	0.98
Property Plant And Equipment Net	0.48	0.95	0.93	-0.17	-0.59	0.94	-0.83	0.87		0.13	-0.96	-0.82	0.95	0.93	0.89	0.47	0.92	0.91	-0.57	0.96	0.93	-0.94	0.24	0.86	0.94	0.94
Current Deferred Revenue	0.48	0.06	0.15	-0.57	-0.29	0.04	-0.4	0.12	0.13		-0.23	0.04	0.2	0.02	0.2	0.59	0.07	-0.1	-0.75	0.12	0.15	-0.16	0.33	0.43	0.12	0.04
Net Debt	-0.64	-0.96	-0.96	0.35	0.69	-0.96	0.86	-0.95	-0.96	-0.23		0.88	-0.99	-0.9	-0.93	-0.51	-0.96	-0.88	0.69	-0.97	-0.96	0.98	-0.39	-0.91	-0.91	-0.96
Accounts Payable	-0.65	-0.83	-0.84	0.48	0.85	-0.87	0.77	-0.88	-0.82	0.04	0.88		-0.86	-0.7	-0.77	-0.47	-0.84	-0.88	0.61	-0.83	-0.84	0.83	-0.24	-0.81	-0.67	-0.87
Cash	0.68	0.98	0.99	-0.34	-0.68	0.98	-0.9	0.97	0.95	0.2	-0.99	-0.86		0.89	0.97	0.54	0.98	0.92	-0.66	0.99	0.99	-0.98	0.29	0.93	0.93	0.98
Non Current Assets Total	0.27	0.92	0.86	0.09	-0.34	0.89	-0.62	0.81	0.93	0.02	-0.9	-0.7	0.89		0.83	0.15	0.89	0.79	-0.37	0.92	0.86	-0.95	0.45	0.68	0.97	0.89
Non Currrent Assets Other	0.72	0.97	0.99	-0.31	-0.6	0.97	-0.9	0.97	0.89	0.2	-0.93	-0.77	0.97	0.83		0.57	0.98	0.9	-0.6	0.98	0.99	-0.94	0.18	0.91	0.92	0.97
Other Assets	0.85	0.43	0.54	-0.8	-0.78	0.46	-0.85	0.51	0.47	0.59	-0.51	-0.47	0.54	0.15	0.57		0.45	0.52	-0.83	0.46	0.54	-0.38	-0.24	0.81	0.32	0.46
Cash And Short Term Investments	0.64	0.99	0.99	-0.25	-0.6	1.0	-0.85	0.99	0.92	0.07	-0.96	-0.84	0.98	0.89	0.98	0.45		0.93	-0.54	0.99	0.99	-0.97	0.25	0.87	0.93	1.0
Net Receivables	0.59	0.93	0.93	-0.25	-0.67	0.95	-0.85	0.91	0.91	-0.1	-0.88	-0.88	0.92	0.79	0.9	0.52	0.93		-0.46	0.92	0.93	-0.86	-0.04	0.84	0.84	0.95
Good Will	-0.82	-0.51	-0.61	0.83	0.83	-0.54	0.81	-0.61	-0.57	-0.75	0.69	0.61	-0.66	-0.37	-0.6	-0.83	-0.54	-0.46		-0.56	-0.61	0.58	-0.34	-0.85	-0.43	-0.54
Non Current Liabilities Total	0.6	1.0	0.99	-0.22	-0.58	0.99	-0.85	0.97	0.96	0.12	-0.97	-0.83	0.99	0.92	0.98	0.46	0.99	0.92	-0.56		0.99	-0.98	0.28	0.88	0.96	0.99
Capital Lease Obligations	0.7	0.99	1.0	-0.32	-0.65	0.99	-0.9	0.98	0.93	0.15	-0.96	-0.84	0.99	0.86	0.99	0.54	0.99	0.93	-0.61	0.99		-0.96	0.21	0.92	0.92	0.99
Inventory	-0.56	-0.98	-0.96	0.22	0.58	-0.97	0.79	-0.95	-0.94	-0.16	0.98	0.83	-0.98	-0.95	-0.94	-0.38	-0.97	-0.86	0.58	-0.98	-0.96		-0.45	-0.85	-0.95	-0.97
Other Current Assets	0.04	0.25	0.21	-0.06	-0.09	0.23	-0.01	0.27	0.24	0.33	-0.39	-0.24	0.29	0.45	0.18	-0.24	0.25	-0.04	-0.34	0.28	0.21	-0.45		0.15	0.3	0.23
Other Stockholder Equity	0.84	0.86	0.92	-0.61	-0.82	0.87	-0.99	0.89	0.86	0.43	-0.91	-0.81	0.93	0.68	0.91	0.81	0.87	0.84	-0.85	0.88	0.92	-0.85	0.15		0.77	0.87
Total Liab	0.4	0.96	0.92	0.01	-0.36	0.93	-0.74	0.86	0.94	0.12	-0.91	-0.67	0.93	0.97	0.92	0.32	0.93	0.84	-0.43	0.96	0.92	-0.95	0.3	0.77		0.93
Net Invested Capital	0.63	0.99	0.99	-0.25	-0.63	1.0	-0.85	0.98	0.94	0.04	-0.96	-0.87	0.98	0.89	0.97	0.46	1.0	0.95	-0.54	0.99	0.99	-0.97	0.23	0.87	0.93

Click cells to compare fundamentals

2Seventy Bio Account Relationship Matchups

Pair Trading with 2Seventy Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if 2Seventy Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 2Seventy Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with 2Seventy Stock

0.62	VKTX	Viking Therapeutics	Pair Corr
0.62	ELEV	Elevation Oncology	Pair Corr

Moving against 2Seventy Stock

0.42

OGN

Organon

Pair Corr

The ability to find closely correlated positions to 2Seventy Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace 2Seventy Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back 2Seventy Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling 2Seventy Bio to buy it.

The correlation of 2Seventy Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as 2Seventy Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if 2Seventy Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for 2Seventy Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for 2Seventy Stock Analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC